N
Nikhil H. Merchant
Researcher at Tata Memorial Hospital
Publications - 16
Citations - 297
Nikhil H. Merchant is an academic researcher from Tata Memorial Hospital. The author has contributed to research in topics: Brachytherapy & Magnetic resonance imaging. The author has an hindex of 9, co-authored 16 publications receiving 274 citations.
Papers
More filters
Journal ArticleDOI
Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India.
Rajat Gupta,V. Seethalakshmi,Nirmala A. Jambhekar,S. Prabhudesai,Nikhil H. Merchant,Ajit S. Puri,Manish Agarwal +6 more
TL;DR: Over 20 years, 470 cases of giant cell tumor of bone diagnosed at a tertiary cancer hospital were analyzed and statistical analysis using the computer software SPSS was performed with particular reference to the unusual histologic features vs recurrence and metastasis by chi(2) test.
Journal ArticleDOI
Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix.
Umesh Mahantshetty,Nehal Khanna,Jamema Swamidas,Meenakshi Thakur,Nikhil H. Merchant,Deepak D. Deshpande,Shyamkishore Shrivastava +6 more
TL;DR: The authors' study evaluating the use of US, suggests a reasonably strong correlation with MR in delineating uterus, cervix, and central disease for 3D conformal intracavitary brachytherapy planning.
Journal ArticleDOI
Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Umesh Mahantshetty,Jamema Swamidas,Nehal Khanna,Nikhil H. Merchant,Deepak D. Deshpande,Shyamkishore Shrivastava +5 more
TL;DR: The 3-D magnetic resonance image-based high dose-rate brachytherapy approach in cervical cancers is feasible, and D0.1cc and D2cc doses to bladder and sigmoid are higher than published literature so far.
Journal ArticleDOI
Chondromyxoid fibromas: a study of 10 cases.
Saral Desai,Nirmala A. Jambhekar,Sagarika Samanthray,Nikhil H. Merchant,Ajay Puri,Manish Agarwal +5 more
TL;DR: The study emphasizes that despite nuclear atypia and recurrences, CMF is a benign disease.
Journal ArticleDOI
18-fluoro-deoxy-glucose positron emission tomography with computed tomography-based gross tumor volume estimation and validation with magnetic resonance imaging for locally advanced cervical cancers.
Maheshkumar N Upasani,Umesh Mahantshetty,Venkatesh Rangarajan,Nilendu Purandare,Nikhil H. Merchant,Meenakshi Thakur,Supriya Chopra,Shyam Kishore Shrivastava +7 more
TL;DR: 18FDG PET-CT SUV-based primary tumor volume estimation at 30% to 35% of SUVmax values correlates significantly with the criterion standard MR volumes for primary cervical tumor with squamous histology in the authors' population.